388

Compound name
Vandetanib
Alt Name
Zactima
Caprelsa
Compound Image
Vandetanib.png
SMILES
CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC
Brutto
C22H24BrFN4O2
InChI
InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)
InChI Key
UHTHHESEBZOYNR-UHFFFAOYSA-N
Approval Jurisdiction
2011 FDA
Approved for clinical use
Thyroid Cancer
CAS
443913-73-3
PubChem CID
3081361
Action
Multiple Tyrosine kinases targeted
Approved Drug List
1
Commercial Vendor
Astra Zeneca